The DOI matches its Crossref record; 34 of the 38 references it cites were found in a registry or an index.
Preclinical Development of Nononcogenic Drugs (Small and Large Molecules)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Irwin, S. (1968) · Psychopharmacology · doi:10.1007/bf00401402 · Cited by 1,240
Drug Metabolites in Safety Testing
Baillie, T. A. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9440 · Cited by 371
Preclinical safety evaluation of biotechnology-derived pharmaceuticals
Cavagnaro, J. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd822 · Cited by 340
Species differences in the structure and function of the immune system
Haley, P. J. (2003) · Toxicology · doi:10.1016/s0300-483x(03)00043-x · Cited by 336
Faed, E. M. (1984) · Drug Metabolism Reviews · doi:10.3109/03602538409033562 · Cited by 299
(2009) · CRC Press eBooks · doi:10.3109/9781420081275-20 · Cited by 163
Timsit, J., Savino, W., Safieh‐Garabedian, B., Chanson, P., Gagnerault, M., Bach, J., & Dardenne, M. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.1.1619008 · Cited by 155
Dissolution Testing of Semisolid Dosage Forms
(2009) · CRC Press eBooks · doi:10.3109/9781420081275-21 · Cited by 128
Preclinical safety testing of monoclonal antibodies: the significance of species relevance
Chapman, K., Pullen, N., Graham, M., & Ragan, I. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2242 · Cited by 121
A Performance Standard for Clinical and Functional Observational Battery Examinations of Rats
Mattsson, J. L., Spencer, P. J., & Albee, R. R. (1996) · Journal of the American College of Toxicology · doi:10.3109/10915819609008716 · Cited by 117
Flagged first, then by citations
4 of the 38 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Emerging issues in probiotic safety: 2023 perspectives
Merenstein, D., Pot, B., Leyer, G., Ouwehand, A. C., Preidis, G. A., Elkins, C. A., Hill, C., Lewis, Z. T., Shane, A. L., Zmora, N., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2185034 · Cited by 481
Preclinical Formulations: Insight, Strategies, and Practical Considerations
Shah, S. M., Jain, A. S., Kaushik, R., Nagarsenker, M. S., & Nerurkar, M. J. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0156-1 · Cited by 80
Das, S., Das, M. K., Jamatia, T., Bhattacharya, B., Mazumder, R., Yadav, P. K., Bishwas, N. R. G., Deka, T., Roy, D., Sinha, B., et al. (2024) · RSC Pharmaceutics · doi:10.1039/d3pm00008g · Cited by 38
Psidium guajava L.: From byproduct and use in traditional Mexican medicine to antimicrobial agent
Gutierrez-Montiel, D., Guerrero-Barrera, A. L., Vela, N. A. C., Avelar-González, F. J., & García, I. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1108306 · Cited by 34
Mazumder, K., Sumi, T. S., Golder, M., Biswas, B., Maknoon, & Kerr, P. G. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113781 · Cited by 26
Metadata
- Authors
- Colerangle, J. B.
- Corresponding author
- Colerangle, J.B.
- Venue
- A Comprehensive Guide to Toxicology in Nonclinical Drug Development
- Publisher
- Elsevier
- Published
- 2017
- Pages
- 659-683
- OpenAlex
- W2488067649
- Cited by
- 37
- References
- 38
- Citations by year
- 2025: 2 · 2024: 6 · 2023: 11 · 2022: 6 · 2021: 5 · 2020: 5 · 2018: 1
- FWCI
- 0.74
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Elsevier eBooks (publishedVersion)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Keywords
- preclinical drug development, biopharmaceuticals, pharmaceuticals, lead candidate selection, formulation development, route of administration, pharmacokinetics, toxicity prediction, animal species selection, epitope expression, therapeutic index, good laboratory practice, ICH guidelines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
